Connect with us

Technology

SEI Expands ETF Platform with SEI QiM U.S. Equity Factor Allocation Active ETF (SEUS)

Published

on

Established Dynamic Active Multifactor Strategy Extends QiM’s Time-Tested Investment Process Through Single-Ticker ETF Solution

OAKS, Pa., July 14, 2026 /PRNewswire/ — SEI® (NASDAQ:SEIC) today announced the launch of the SEI QiM U.S. Equity Factor Allocation Active ETF (NASDAQ:SEUS), an actively managed core U.S. equity solution that brings SEI’s established U.S. Equity Factor Allocation strategy to the ETF market. Managed by SEI’s Quantitative Investment Management (QiM) team, SEUS provides access to a time-tested investment process through a transparent, cost-effective ETF structure that offers accessibility, scalability, and tax efficiency.

SEUS is based on the same dynamic active factor allocation approach that QiM has implemented across other investment vehicles, combining dynamic factor allocation, active stock selection, and disciplined risk management within a diversified equity portfolio. Designed as a core equity allocation, the ETF seeks to adapt as market conditions evolve while maintaining exposure to historically rewarded factors through a risk-aware investment process.

Powered by SEI’s Quantitative Investment Management team, which manages more than $30 billion in quantitative investment strategies as of March 31, 2026, SEUS leverages proprietary factor research, integrated risk models, and dedicated portfolio management oversight. The launch extends an established investment process through a flexible, transparent, and tax-efficient ETF structure, providing investors with access to the same underlying philosophy, research framework, and portfolio management expertise.

Commenting on the ETF launch, Robert Hum, Head of Investment Product and Commercialization at SEI, said:

“Markets are increasingly dynamic, and investors need strategies that can adapt alongside them. SEUS expands access to QiM’s established investment process, bringing a time-tested active multifactor strategy to investors through a transparent, tax-efficient, single-ticker ETF solution. By combining dynamic factor allocation, active stock selection, and disciplined risk management, SEUS is designed to help investors navigate evolving market environments while maintaining diversified U.S. equity exposure.”

About SEI®

SEI (NASDAQ:SEIC) is a leading global provider of financial technology, operations, and asset management services within the financial services industry. SEI tailors its solutions and services to help clients more effectively deploy their capital—whether that’s money, time, or talent—so they can better serve their clients and achieve their growth objectives. As of March 31, 2026, SEI manages, advises, or administers approximately $1.9 trillion in assets. For more information, visit seic.com.

SEI Investments Management Corporation (SIMC) is the advisor to the SEI Funds, which are distributed by SEI Investments Distribution Co. (SIDCO). SIMC and SIDCO are wholly owned subsidiaries of SEI Investments Company (SEI). The Quantitative Investment Management team is a team within SIMC.

To determine if the Funds are an appropriate investment for you, carefully consider the investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the Funds’ summary and full prospectuses, which may be obtained by calling 1-800-DIAL-SEI. Read it carefully before investing.

There are risks involved with investing, including loss of principal. There is no guarantee an investment objective will be achieved, nor that risk can be managed successfully. Diversification may not protect against market risk. The Fund may trade securities actively, which could increase its transaction costs (thereby lowering its performance) and could increase the amount of taxes you owe by generating short-term gains, which may be taxed at a higher rate.

Mutual funds and ETFs are obliged to distribute portfolio gains to shareholders by year-end. These gains may be generated due to index rebalancing or to meet diversification requirements. However, ETFs are structured in such a manner that taxes are minimized compared to a similarly structured mutual fund. Trading shares of the ETFs will also generate tax consequences and transaction expenses.

There can be no assurance that performance will be enhanced or risk will be reduced for investment strategies that seek to provide exposure to certain quantitative factors. Exposure to such investment factors may detract from performance in certain market environments, in some cases for extended periods. In such circumstances, an investment strategy may seek to maintain exposure to the targeted investment factors and not adjust to target different factors, which could result in losses. While the Fund is actively managed, the investment process is expected to be heavily dependent on quantitative models, and the models may not perform as intended.

Forward-looking statements

This communication contains forward-looking statements within the meaning of the rules and regulations of the Securities and Exchange Commission. In some cases, you can identify forward looking statements by terminology, such as “may,” “will,” “expect,” “believe,” “can,” “continue,” “seek,” or similar expressions.

SEI’s forward-looking statements include its current expectations as to:

The benefits, if any, that our ETF products offer to investors

You should not place undue reliance on any forward-looking statements, as they are based on the current beliefs and expectations of management and are subject to significant risks and uncertainties, many of which are beyond management’s control or are subject to change. Although management believes the assumptions upon which the forward-looking statements are based are reasonable, they could be inaccurate. Some of the risks and important factors that could cause actual results to differ from those described in SEI’s forward looking statements can be found in the “Risk Factors” section of SEI’s Annual Report on Form 10 K for the year ended Dec. 31, 2025, filed with the Securities and Exchange Commission. SEI undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Media Contact:
Eric Hazard
Vested
+1 917-765-8720
eric@fullyvested.com

View original content:https://www.prnewswire.com/news-releases/sei-expands-etf-platform-with-sei-qim-us-equity-factor-allocation-active-etf-seus-302825214.html

SOURCE SEI Investments Company

Continue Reading

Technology

Kibow® Biotech Announces Availability of Renadyl® in Canada

Published

on

By

Expansion Brings Clinically Studied Kidney Probiotic to
More People Seeking to Maintain Kidney Health

EXTON, Pa., Nov. 19, 2026 /PRNewswire/ — Kibow Biotech, a leading innovator in probiotic dietary supplements for kidney health, today announced the availability of its flagship product, Renadyl, in Canada, marking another important milestone in the company’s mission to expand access to innovative, science-based kidney health solutions worldwide.

Developed through decades of research into the relationship between gut health and kidney function, Renadyl is a patented, clinically studied probiotic supplement scientifically formulated to help maintain healthy kidney function. Its unique approach focuses on the gut microbiome and its role in managing certain waste compounds that can place additional demands on the kidneys.

“Expanding Renadyl’s availability into Canada represents an exciting step forward in our mission to make innovative kidney health solutions accessible to more people,” said Mike Kane, President of Kibow Biotech. “Since 1997, we have been committed to advancing the science behind the gut-kidney connection and developing products that help people take a more proactive role in maintaining their kidney health. We are pleased to bring Renadyl to Canadians looking for additional ways to support their kidney health.”

Chronic Kidney Disease (CKD) affects millions of people worldwide, creating a growing need for approaches that complement traditional kidney care. Renadyl offers a gut-based approach to kidney support, using specially selected probiotic strains to help metabolize certain waste compounds in the intestinal tract and support healthy kidney function.

“As a kidney health advocate and someone who understands firsthand the challenges of living with Chronic Kidney Disease, I am excited to see Renadyl becoming available to more people around the world,” said James Fabin, founder of Dadvice TV and kidney health advocate. “People living with CKD are always looking for ways to take a more active role in their kidney health. Expanding access to products like Renadyl gives more people the opportunity to explore additional options and have informed conversations with their healthcare providers.”

Renadyl features a proprietary blend of three probiotic strains delivering 45 billion colony-forming units (CFUs) per daily serving. Designed to work within the intestinal environment, these beneficial bacteria help support the body’s natural processes for managing certain waste compounds while promoting a healthier gut environment.

The Canadian introduction builds on Kibow Biotech’s longstanding commitment to scientific research, product innovation, and education about the important relationship between gut health and kidney function.

Renadyl is now available to Canadian consumers at Renadyl.ca, where they can purchase the product and learn more about its benefits and how it works.

About Kibow Biotech, LLC
Founded October 1,1997, in Philadelphia, PA, the company’s primary mission is to offer affordable, readily available, and easily administered nutritional supplements to support kidney health and other healthcare applications. Kibow Biotech’s extensive scientific (R&D) and clinical data from multiple studies and scientific human clinical trials have been published in peer-reviewed scientific/medical journals (kibowbiotech.com/rd). The company’s flagship product, Renadyl, is marketed around the world.

Contact Information:
Michelle Adams
President
PRISM Marketing
614-989-6373
michelle@prismmarketing.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/kibow-biotech-announces-availability-of-renadyl-in-canada-302945880.html

SOURCE Kibow Biotech

Continue Reading

Technology

Aptitude 8 Joins the Claude Partner Network as a Select Services Partner

Published

on

By

The recognition formalizes the Claude work Aptitude 8 has already been delivering for enterprise clients and strengthens its AI services practice.

NEW YORK, Nov. 19, 2026 /PRNewswire-PRWeb/ — Aptitude 8, a go-to-market (GTM) operations firm specializing in AI systems, today announced that it has achieved the Select partner tier in the Claude Partner Network Services Track. The tier places Aptitude 8 among the firms recognized for taking customers from pilot programs to production at scale with Claude, powered by Anthropic.

Aptitude 8’s dedicated team of certified Claude architects incorporates Claude into clients’ GTM systems and aligns the data and process it runs on. The firm is continuing to grow its certified Claude team within its AI services practice.

“AI has become essential to how businesses compete, and the companies seeing success are building it on the right foundation, wherever they’re starting from,” said Rob Guinn, CEO of Aptitude 8. “That takes deep expertise in both Claude and the data it runs on, and that combination is exactly what our team brings. Becoming a Select partner means more companies can tap into that expertise as they put Claude to work across their teams.”

Most AI initiatives stall because the system underneath them was never designed for AI. Claude fits the work Aptitude 8 already does across its clients: GTM system implementation, data architecture, systems integration, CRM engineering and portal development. Aptitude 8 architects Claude as the AI layer of a company’s GTM system and the CRM as its context layer, so Claude works from the customer’s own data and process rather than sitting beside them as a separate tool.

Aptitude 8’s Claude work spans MCP architecture that connects Claude to HubSpot and the rest of a company’s stack, custom Claude skill development, design system builds in Claude Design, and enablement and training, including Claude Code for non-developers. As usage grows, the team also helps clients manage token spend so Claude can scale with the business.

Aptitude 8’s work with Claude is already running in production for clients. For a professional services firm, Aptitude 8 turned scattered Claude usage into standardized skills, scheduled tasks and CRM workflows across sales, marketing and delivery, returning more than 1,000 hours of team capacity a year. Every proposal the firm writes now runs through Claude. For a B2B software company, Aptitude 8 built Claude Design and Claude Code workflows and a codebase agent that cut the engineering time spent triaging support requests by 80%.

To mark the announcement, Aptitude 8 is offering a free consultation; book your call at aptitude8.com/claude-services. Learn more about the Claude Partner Network at claude.com/partners.

About Aptitude 8

Aptitude 8 is a go-to-market (GTM) operations firm that architects the systems behind how businesses market, sell, and serve their customers. Deeply rooted in the HubSpot ecosystem, Aptitude 8 brings vast expertise across GTM technology and AI platforms, including Claude, to connect data, align processes, and build the infrastructure businesses need to operate more efficiently and put AI to work. The firm leads with strategy, challenges assumptions, and designs systems built to scale. Aptitude 8 makes growth operationally sound for its customers.

About the Claude Partner Network

The Claude Partner Network is how Anthropic works with the firms that put Claude into production for customers. The Services Track recognizes partners for building a certified delivery team, delivering Claude use cases for clients, and proving the work through public customer references. Partners advance through Certified, Select, Preferred, and Global Premier tiers.

Media Contact

Emily Wingrove, Aptitude 8, 1 302-428-9465, marketing@aptitude8.com, https://aptitude8.com/

View original content to download multimedia:https://www.prweb.com/releases/aptitude-8-joins-the-claude-partner-network-as-a-select-services-partner-302945796.html

SOURCE Aptitude 8

Continue Reading

Technology

Sedgwick White Paper Shows How to Separate Controllable Auto Claim Severity Drivers from Market Pressure

Published

on

By

Five-step framework and auto claim triage guide help carriers identify where claim-process friction is adding avoidable cost and delay

MEMPHIS, Tenn., Nov. 19, 2026 /PRNewswire/ — Rising auto claims severity can feel unprecedented, but Sedgwick has seen this pattern before. In the white paper, The severity you can control: A five-step framework for action, Sedgwick draws on insight from approximately 1 million auto claims every year and decades of historical claims data. Sedgwick shares what’s driving severity and what tends to happen next. Some severity is driven by market conditions. 

Overall, claim frequency has declined across several physical damage coverages, but pressure on carriers remains. Total losses are becoming more common; bodily injury severity continues to rise, and increasingly technical vehicles are changing what it takes to repair and resolve a claim. 

According to CCC Intelligent Solutions, the average paid bodily injury claim rose 10.3% year over year, and 23.1% of claims were flagged as a total loss, a record high across all loss categories. CCC also reports that advanced driver assistance systems (ADAS), sensors and cameras now trigger calibrations on nearly three in ten repairable estimates. Meanwhile, U.S. consumer price data show auto repair costs rose 60% from 2019 to 2026, nearly double the 32% rise in overall inflation. 

“Carriers don’t need more capabilities for their own sake. They need to know where a practical change will make a measurable difference. This framework gives claims leaders a way to find those opportunities and track whether they’re working,” said Chris Bakes, Managing Director, Auto Solutions at Sedgwick. “We know that some severity lives in the sheet metal and some lives in the claim process. The first can only be managed. The second can be controlled.” 

The white paper also outlines Sedgwick insights for evaluating where operational change can create the most value by applying an interactive framework developed by Sedgwick’s auto solutions experts to assess your operation and prioritize cost-containment opportunities for 2027. 

“Towing and storage is a clear example of how timing affects costs. Our towing and storage solution combines claims expertise and technology across negotiation, payment, vehicle release and transfer, helping claims teams act sooner. The result is an average bill of $1,770 versus a $2,600 industry average, a 32% reduction,” said Tim Szpila, Sr. Vice President Business Development at Sedgwick. 

The white paper also includes an auto claim triage guide that shows how information available at first notice of loss (FNOL), such as damage severity, drivability, airbag deployment and vehicle classification, can inform the likely inspection and handling path. A companion set of self-assessment questions helps carriers capture findings and identify priorities. 

The severity you can control: A five-step framework for action white paper is available at online.

About Sedgwick 
Sedgwick is the world’s leading risk and claims administration partner, helping clients thrive by navigating the unexpected. The company’s expertise, combined with the most advanced AI-enabled technology available, sets the standard for solutions in claims administration, loss adjusting, benefits administration and product recall. With over 33,000 colleagues and 10,000 clients across 80 countries, Sedgwick provides unmatched perspective, caring that counts, and solutions for the rapidly changing and complex risk landscape. Sedgwick’s majority shareholder is The Carlyle Group; Stone Point Capital LLC, Altas Partners, CDPQ, Onex and other management investors are minority shareholders. For more, see sedgwick.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sedgwick-white-paper-shows-how-to-separate-controllable-auto-claim-severity-drivers-from-market-pressure-302945902.html

SOURCE Sedgwick Claims Management Services, Inc.

Continue Reading

Trending